Brief: Foghorn Therapeutics Provides Q1 2023 Financial And Corporate Update

Foghorn Therapeutics

08/05/2023 15:39

May 8 (Reuters) - Foghorn Therapeutics Inc.  FHTX.O :
    * FOGHORN THERAPEUTICS PROVIDES FIRST QUARTER 2023 FINANCIAL
AND
CORPORATE UPDATE
    * FOGHORN THERAPEUTICS -CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES OF $316.0 MILLION, AS OF MARCH 31, 2023, PROVIDES
CASH RUNWAY INTO SECOND HALF OF 2025
    * QTRLY LOSS PER SHARE $0.73
    * FOGHORN THERAPEUTICS  - QTRLY COLLABORATION REVENUE WAS
$5.3
MILLION, COMPARED TO $3.9 MILLION FOR THREE MONTHS ENDED MARCH
31, 2022
    * Q1 EARNINGS PER SHARE VIEW $-0.73, REVENUE VIEW $5.0
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5BwMnm 
Further company coverage:  FHTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))